KWM
DARE icon

Kingsview Wealth Management’s Dare Bioscience DARE Stock Holding History

Kingsview Wealth Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-89
Closed -$5K – 376
2017
Q2 		$5K Hold
89
– – ﹤0.01% 287
2017
Q1 		$9K Buy
+89
New +$12.8K 0.01% 246

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return

Kingsview Wealth Management's DARE Position: Q3 2017 in Review

Kingsview Wealth Management sold out of Dare Bioscience (DARE) in Q3 2017, closing a stake of 89 shares — an estimated $5K sold.

Kingsview Wealth Management first reported a position in DARE in Q1 2017 and held it in 2 quarters. The position peaked at $9K in Q1 2017. 13 funds tracked by Wall St. Rank hold DARE as of Q3 2017.

  • Kingsview Wealth Management reported no remaining Dare Bioscience position as of Q3 2017 after selling out during the quarter.
  • Kingsview Wealth Management sold 89 Dare Bioscience shares in Q3 2017, an estimated $5K.
  • Kingsview Wealth Management first reported a position in Dare Bioscience in Q1 2017 and held it in 2 quarters.
  • Kingsview Wealth Management's Dare Bioscience position peaked at $9K in Q1 2017.
  • 13 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2017.

Based on Kingsview Wealth Management's 13F filing for Q3 2017, filed 29 Jan 2020.